Powles, T <br/><br/>
The safety and efficacy of sunitinib before planned nephrectomy in metastatic clear cell renal cancer.  [electronic resource] 

 -  Annals of oncology : official journal of the European Society for Medical Oncology  May 2011 
 - 1041-1047 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase II; Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1569-8041 
<br/><br/><label>Standard No.: </label>10.1093/annonc/mdq564  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Antineoplastic Agents--adverse effects<br/>Bone Neoplasms--pathology<br/>Carcinoma, Renal Cell--mortality<br/>Disease-Free Survival<br/>Female<br/>Humans<br/>Indoles--adverse effects<br/>Kaplan-Meier Estimate<br/>Kidney Neoplasms--mortality<br/>Liver Neoplasms--pathology<br/>Lung Neoplasms--pathology<br/>Lymphatic Metastasis<br/>Male<br/>Middle Aged<br/>Neoadjuvant Therapy--adverse effects<br/>Nephrectomy<br/>Prospective Studies<br/>Pyrroles--adverse effects<br/>Sunitinib<br/>Treatment Outcome<br/>Tumor Burden--drug effects